Etoricoxib in pharma franchise in Kerala

Etoricoxib in PCD pharma franchise in Dispur

Etoricoxib in top pharma company in Rajkot

Etoricoxib in pcd pharma supplier in Raipur

Etoricoxib in phama franchise company in India
Etoricoxib in phama distributor in Belagavi

Home/Products /etoricoxib-60mg-tablet

Etoscrib 60 Tablet

Composition : Etoricoxib (60mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹85/-

Etoscrib 60 Tablet is a non-steroidal anti-inflammatory drug (NSAID) containing etoricoxib, which is effective in managing pain and inflammation. This medication is primarily indicated for the treatment of various conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Etoscrib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a crucial role in the inflammatory process. By reducing the production of prostaglandins, Etoscrib alleviates symptoms such as swelling, tenderness, and stiffness, enhancing the quality of life for individuals suffering from chronic pain conditions.

Patients using Etoscrib can expect significant relief from pain associated with both acute and chronic inflammatory conditions. Its formulation allows for a convenient once-daily dosing schedule, making it easier for patients to adhere to their treatment regimen. It is advisable to take the tablet as prescribed by a healthcare professional, ensuring optimal results and minimizing the risk of side effects.

Read More

About the Product

Etoscrib 60 Tablet is a non-steroidal anti-inflammatory drug (NSAID) containing etoricoxib, which is effective in managing pain and inflammation. This medication is primarily indicated for the treatment of various conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Etoscrib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a crucial role in the inflammatory process. By reducing the production of prostaglandins, Etoscrib alleviates symptoms such as swelling, tenderness, and stiffness, enhancing the quality of life for individuals suffering from chronic pain conditions.

Patients using Etoscrib can expect significant relief from pain associated with both acute and chronic inflammatory conditions. Its formulation allows for a convenient once-daily dosing schedule, making it easier for patients to adhere to their treatment regimen. It is advisable to take the tablet as prescribed by a healthcare professional, ensuring optimal results and minimizing the risk of side effects.

Common side effects may include gastrointestinal discomfort, headaches, dizziness, and elevated blood pressure. Serious side effects can occur, such as cardiovascular events and gastrointestinal bleeding.

Etoscrib 60 Tablet is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain.

Consult a healthcare provider before use, especially if you have a history of cardiovascular disease, gastrointestinal issues, or kidney problems. Do not exceed the recommended dosage.

Store Etoscrib 60 Tablet in a cool, dry place away from direct sunlight and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation